
Plasma phosphorylated tau protein (p-tau217) testing can accurately identify preclinical Alzheimer's disease in cognitively unimpaired adults, potentially streamlining clinical trial recruitment and reducing the need for more invasive diagnostic tests.


coremsg

Plasma p-tau217 can identify Alzheimer's disease pathology with high accuracy in cognitively normal adults, which could aid clinical trial recruitment.

Tau Blood Test Flags Preclinical Alzheimer's Disease

plasma-phosphorylated-tau-protein-p-tau217-test-accurately-identifies-preclinical-alzheimer-s-disease-in-cognitively-unimpaired-adults


Plasma Phosphorylated Tau Protein (p-tau217) Test Accurately Identifies Preclinical Alzheimer's Disease in Cognitively Unimpaired Adults
